Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000385202

Medchemexpress LLC Atazanavir | 198904-31-3 | MFCD09839958 | >98% | 704.86 | 50 MG
SDP

Catalog No. 5000385202
Encompass_Preferred

Atazanavir (BMS-232632) is a highly selective and orally active HIV-1 protease inhibitor. Atazanavir is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. Atazanavir inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death.

  • HIV-1 protease inhibitor.
  • Substrate and inhibitor of CYP3A4.
  • Inhibitor of P-glycoprotein (P-gp).
  • SARS-CoV 3CLpro inhibitor (IC50 = 3.49 μM).
  • Inhibits cardiac fibrosis and hyperlipidemia.
  • Induces malignant glioma death.

Catalog No. 50-003-85202 Supplier Medchemexpress LLC Supplier No. HY1736750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Atazanavir (BMS-232632) is a highly selective and orally active HIV-1 protease inhibitor. Atazanavir is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. Atazanavir inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death.

  • HIV-1 protease inhibitor.
  • Substrate and inhibitor of CYP3A4.
  • Inhibitor of P-glycoprotein (P-gp).
  • SARS-CoV 3CLpro inhibitor (IC50 = 3.49 μM).
  • Inhibits cardiac fibrosis and hyperlipidemia.
  • Induces malignant glioma death.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.